NCT07723651 · Interventional trial
[18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC)
Overall registry status Recruiting
Phase 2
Conditions Metastatic Prostate Cancer, Prostate Cancer
Delaware Valley sites
- University of Pennsylvania Abramson Cancer Center · Philadelphia, PA · Philadelphia County · Not yet recruiting
First posted
Registry updated
Added to the directory